Docgo vs Omada Health
Docgo is the larger business, with $322m of revenue in fiscal 2025 against $260m for Omada Health (1.2 times as much). Omada Health grew faster (53.2% against -47.7%). Omada Health kept more of each dollar of sales as profit: a net margin of -4.9% against -56.6%.
| Latest fiscal year | DocgoDCGO, 2025 | Omada HealthOMDA, 2025 |
|---|---|---|
| Revenue | $322m | $260m |
| Revenue growth | -47.7% | 53.2% |
| Net income | −$182m | −$12.8m |
| Operating margin | — | -4.6% |
| Net margin | -56.6% | -4.9% |
| Return on equity | -78.5% | — |
| Free cash flow | $29.9m | $16.9m |
| Cash | $51.0m | $222m |
| Total debt | $287,323 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $10.8m | — |
| Employees | 3,600 | 916 |
| Market value | $25.6m | $1.12bn |
| Price vs our value range | — | — |
| Moat score | 18 (Weak) | — |
| Insider trades, 12 months | 0 buys, 1 sales | 0 buys, 77 sales |